388 related articles for article (PubMed ID: 38270182)
1. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Walker E; Osborn DA
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
[TBL] [Abstract][Full Text] [Related]
2. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
[TBL] [Abstract][Full Text] [Related]
3. Nasal high flow therapy for primary respiratory support in preterm infants.
Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ
Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
Subramaniam P; Ho JJ; Davis PG
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
[TBL] [Abstract][Full Text] [Related]
6. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Osborn DA
Cochrane Database Syst Rev; 2011 Jul; (7):CD008309. PubMed ID: 21735428
[TBL] [Abstract][Full Text] [Related]
7. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
[TBL] [Abstract][Full Text] [Related]
8. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
[TBL] [Abstract][Full Text] [Related]
9. Inositol in preterm infants at risk for or having respiratory distress syndrome.
Howlett A; Ohlsson A; Plakkal N
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
[TBL] [Abstract][Full Text] [Related]
10. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
[TBL] [Abstract][Full Text] [Related]
11. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive high-frequency ventilation in newborn infants with respiratory distress.
Abdel-Latif ME; Tan O; Fiander M; Osborn DA
Cochrane Database Syst Rev; 2024 May; 5(5):CD012712. PubMed ID: 38695628
[TBL] [Abstract][Full Text] [Related]
13. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
[TBL] [Abstract][Full Text] [Related]
14. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Osborn DA
Cochrane Database Syst Rev; 2012 Oct; 10():CD008310. PubMed ID: 23076945
[TBL] [Abstract][Full Text] [Related]
15. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
[TBL] [Abstract][Full Text] [Related]
16. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532
[TBL] [Abstract][Full Text] [Related]
17. Methylxanthine for the prevention and treatment of apnea in preterm infants.
Marques KA; Bruschettini M; Roehr CC; Davis PG; Fiander M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013830. PubMed ID: 37905735
[TBL] [Abstract][Full Text] [Related]
18. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; van de Loo M; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887
[TBL] [Abstract][Full Text] [Related]
19. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
20. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
